Dalrada Financial (DFCO) Stock Price, News & Analysis

Company Overview

Dalrada Financial Corporation, doing business as Dalrada Corporation, is a diversified technology company focused primarily on healthcare, clean energy and related industrial solutions. The company has described its operations as centered on developing and commercializing products and services intended to address healthcare delivery, energy efficiency and sustainability needs.

Through its healthcare businesses, Dalrada has pursued diagnostic, pharmaceutical, medical-device and healthcare-service opportunities, including precision-medicine and telehealth-related initiatives. Its clean-energy activities have included high-efficiency heating and cooling systems and other technologies designed to reduce energy consumption and emissions. The company has operated through subsidiaries and business units associated with brands such as Dalrada Health, Genefic and Likido.

Dalrada is headquartered in the United States and has stated that it serves customers and commercial partners in multiple geographic markets, although the scope of its operations and product offerings may change as the company develops its businesses. Company materials have identified Brian Bonar as chairman and chief executive officer. Dalrada was historically known as Dalrada Financial Corporation before adopting the Dalrada Corporation name as its business focus evolved.

Key Stats

• Today's Range: $0.04 to $0.04
• 50-Day Range: $0.04 to $0.04
• 52-Week Range: $0.00 to $0.11
• Volume: N/A
• Average Volume: 53,068 shs
• Market Capitalization: $4.21 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 11/13/2026
• Fiscal Year End: 6/30/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Industrials
• Industry: Commercial Services & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:DFCO
• CIK: 725394
• Web: www.dalrada.com
• Phone: (858) 283-1253
• Fax: 858-277-3448
• Employees: 6
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.22)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$24.65 million
• Net Margins: -121.21%
• Pretax Margin: -121.47%
• Return on Equity: N/A
• Return on Assets: -104.62%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.49
• Quick Ratio: 0.32

Sales & Book Value

• Annual Sales: $20.30 million
• Price / Sales: 0.21
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.15) per share
• Price / Book: -0.23

Miscellaneous

• Outstanding Shares: 120,157,000
• Free Float: 111,686,000
• Market Cap: $4.21 million
• Optionable: Not Optionable
• Beta: 0.97